- hydronephrosis / MGI
- abnormal forelimb morphology / MGI
- abnormal liver development / MGI
- small liver / MGI
- enlarged liver sinusoidal spaces / MGI
- abnormal myogenesis / MGI
- abnormal muscle development / MGI
- thin diaphragm muscle / MGI
- abnormal tongue morphology / MGI
- small cerebellum / MGI
- abnormal motor neuron innervation pattern / MGI
- abnormal somatic motor system morphology / MGI
- impaired coordination / MGI
- decreased embryo size / MGI
- abnormal placenta development / MGI
- decreased trophoblast giant cell number / MGI
- abnormal placenta labyrinth morphology / MGI
- postnatal growth retardation / MGI
- increased mammary adenocarcinoma incidence / MGI
- respiratory failure / MGI
- neoplasm / MGI
- increased tumor incidence / MGI
- increased sarcoma incidence / MGI
- increased carcinoma incidence / MGI
- premature death / MGI
- no abnormal phenotype detected / MGI
- abnormal diaphragm morphology / MGI
- glomerulonephritis / MGI
- no phenotypic analysis / MGI
- abnormal muscle precursor cell migration / MGI
- hypaxial muscle hypoplasia / MGI
- decreased liver weight / MGI
- nervous system phenotype / MGI
- abnormal axon extension / MGI
- increased hemangiosarcoma incidence / MGI
- diaphragmatic hernia / MGI
- chromosome breakage / MGI
- abnormal tongue muscle morphology / MGI
- abnormal fetal growth/weight/body size / MGI
- decreased fetal size / MGI
- increased squamous cell carcinoma incidence / MGI
- small placenta / MGI
- pale placenta / MGI
- abnormal neuron physiology / MGI
- decreased skeletal muscle mass / MGI
- absent skeletal muscle / MGI
- muscle phenotype / MGI
- embryo phenotype / MGI
- abnormal liver parenchyma morphology / MGI
- increased histiocytic sarcoma incidence / MGI
- paraparesis / MGI
- reduced cerebellar foliation / MGI
- decreased tongue size / MGI
- abnormal neuron differentiation / MGI
- decreased lung tumor incidence / MGI
- increased mammary gland tumor incidence / MGI
- mortality/aging / MGI
- neonatal lethality, complete penetrance / MGI
- prenatal lethality, complete penetrance / MGI
- embryonic lethality between implantation and somite formation, complete penetrance / MGI
- embryonic lethality during organogenesis, complete penetrance / MGI
- lethality throughout fetal growth and development, complete penetrance / MGI
- absent diaphragm / MGI
- increased myoepithelioma incidence / MGI
- abnormal diaphragm development / MGI
- increased lymphoma incidence / MGI
- abnormal intrinsic tongue muscle morphology / MGI
C57BL/6N-Mettm2(MET*)Tcre/Cnrm
Status | Available to order |
EMMA ID | EM:13663 |
Citation information | RRID:IMSR_EM:13663 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6N-Mettm2(MET*)Tcre/Cnrm |
Alternative name | Ex14Del-ki |
Strain type | Targeted Mutant Strains : Knock-in |
Allele/Transgene symbol | Mettm2(MET*)Tcre |
Gene/Transgene symbol | Met |
Information from provider
Provider | PAOLO COMOGLIO |
Provider affiliation | IFOM - Istituto FIRC di Oncologia Molecolare |
Additional owner | Tiziana Crepaldi, Ph.D., Department of Oncology, University of Turin, Candiolo Cancer Institute, Candiolo (Torino) ITALY |
Genetic information | Ex14Del-ki mice harbour the "humanized" knock-in mutation of the human MET allele without exon 14, which replaces the mouse Met gene. The coding region of exon 3 plus partial intron 3 was replaced with the mutant human MET CDS without exon 14 (NM_000245.4; 4032 bp). C57BL/6N ES cells were used for gene targeting. |
Phenotypic information | Homozygous:not knownHeterozygous:Mice heterozygous for the Ex14Del-ki allele are viable and fertile. |
Breeding history | The Ex14Del-ki mice were bred with C57BL/6N to generate the heterozygous mice. |
References | None available |
Homozygous fertile | not known |
Homozygous viable | not known |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Pediatric hepatocellular carcinoma / Orphanet_33402
- Papillary renal cell carcinoma / Orphanet_319298
- Osteofibrous dysplasia / Orphanet_488265
- Autosomal recessive non-syndromic sensorineural deafness type DFNB / Orphanet_90636
- Hereditary papillary renal cell carcinoma / Orphanet_47044
MGI phenotypes (gene matching)
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).